Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Diabetic Medicine : a Journal of the British Diabetic Association|January 14, 2022
The impact of birthweight on subsequent phenotype of type 2 diabetes in later lifeChristian Paulina, Louise A Donnelly, Ewan R PearsonDiabetologia|July 5, 2024
Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world populationLouise A Donnelly, Rory J McCrimmon, Ewan R PearsonClinical Endocrinology|March 5, 2016
Liothyronine use in a 17 year observational population-based study - the tears studyGraham P Leese, Enrique Soto-Pedre, Louise A DonnellyDiabetes, Obesity & Metabolism|November 5, 2025
One-year usage patterns of SGLT-2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes in a real-world populationLouise A Donnelly, Katyayeni Singh, Rory J McCrimmon, et al.Diabetic Medicine : a Journal of the British Diabetic Association|November 25, 2020
In a cohort of individuals with type 2 diabetes using the drug sulfasalazine, HbA<sub>1c</sub> lowering is associated with haematological changesSamira M S N'Dow, Louise A Donnelly, Ewan R Pearson, et al.Diabetes, Obesity & Metabolism|June 29, 2017
Interaction between variants in the CYP2C9 and POR genes and the risk of sulfonylurea-induced hypoglycaemia: A GoDARTS StudyTanja Dujic, Kaixin Zhou, Louise A Donnelly, et al.Diabetes|December 17, 2014
Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS StudyTanja Dujic, Kaixin Zhou, Louise A Donnelly, et al.Diabetologia|December 21, 2017
Rates of glycaemic deterioration in a real-world population with type 2 diabetesLouise A Donnelly, Kaixin Zhou, Alex S F Doney, et al.Journal of Hypertension|June 18, 2004
How much echo left ventricular hypertrophy would be missed in diabetics by applying the Losartan Intervention For Endpoint Reduction electrocardiogram criteria to select patients for angiotensin receptor blockade?Adelle Dawson, Bushra S Rana, Stuart D Pringle, et al.Diabetes Care|July 1, 2009
New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetesGillian Libby, Louise A Donnelly, Peter T Donnan, et al.Pageof 5